These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36644740)

  • 1. A Single-Center, Retrospective Cohort Study Evaluating the Use of Probiotics for the Prevention of Hospital-Onset
    Shah PJ; Halawi H; Kay J; Akogun A; Wise S; Aly S; Daoura N; Putney D
    Hosp Pharm; 2023 Feb; 58(1):57-61. PubMed ID: 36644740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
    Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
    Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of probiotics on the incidence of Clostridioides difficile: Retrospective cohort analysis.
    Saltzman T; Fazzari M; Chung S; Cunha BA; Blum S
    Am J Infect Control; 2020 Feb; 48(2):184-188. PubMed ID: 31606256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Probiotics on the Development of
    Sheffield ME; Jones BM; Terrell B; Wagner JL; Bland CM
    Pharmacy (Basel); 2021 Aug; 9(3):. PubMed ID: 34449745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
    Lewis PO; Lundberg TS; Tharp JL; Runnels CW
    Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribed probiotic usage to prevent Clostridioides difficile infection among older patients receiving antibiotics: A retrospective cohort study.
    Mori N; Katsumata T; Takahashi T
    J Infect Chemother; 2023 Sep; 29(9):833-837. PubMed ID: 37211085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
    Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
    Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost and length of hospital stay for healthcare facilityonset Clostridioides Difficile infection in pediatric wards: a prospective cohort analysis.
    Demir SÖ; Kepenekli E; Akkoç G; Yakut N; Soysal A
    Turk J Pediatr; 2021; 63(6):1004-1011. PubMed ID: 35023650
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    MacKenzie EL; Murillo C; Bartlett AH; Marrs R; Landon EM; Ridgway JP
    Infect Control Hosp Epidemiol; 2023 Nov; 44(11):1782-1787. PubMed ID: 36658099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.
    Freedberg DE; Salmasian H; Friedman C; Abrams JA
    Am J Gastroenterol; 2013 Nov; 108(11):1794-801. PubMed ID: 24060760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between antiulcer agents and Clostridioides difficile infection in patients receiving antibiotics: A retrospective cohort study using the diagnosis procedure combination database in Japan.
    Ishida R; Seki T; Kawakami K
    Anaerobe; 2022 Jun; 75():102537. PubMed ID: 35202792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of Clostridioides difficile Infection Among Asymptomatic, Colonized Patients: A Retrospective Cohort Study.
    Poirier D; Gervais P; Fuchs M; Roussy JF; Paquet-Bolduc B; Trottier S; Longtin J; Loo VG; Longtin Y
    Clin Infect Dis; 2020 May; 70(10):2103-2210. PubMed ID: 31290544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection.
    Wombwell E
    Microbes Infect; 2023; 25(3):105041. PubMed ID: 36058513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of probiotics in preventing
    Barbosa MLL; Albano MO; Martins CDS; Warren CA; Brito GAC
    Front Med (Lausanne); 2023; 10():1219225. PubMed ID: 37636573
    [No Abstract]   [Full Text] [Related]  

  • 16. Using diagnostic stewardship to reduce rates, healthcare expenditures and accurately identify cases of hospital-onset
    Solanky D; Juang DK; Johns ST; Drobish IC; Mehta SR; Kumaraswamy M
    Infect Control Hosp Epidemiol; 2021 Jan; 42(1):51-56. PubMed ID: 32943129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Community Factors with Hospital-onset
    Zacharioudakis IM; Zervou FN; Shehadeh F; Mylona EK; Mylonakis E
    EClinicalMedicine; 2019 Feb; 8():12-19. PubMed ID: 31193719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDC's Hospital-Onset Clostridioides difficile Prevention Framework in a Regional Hospital Network.
    Turner NA; Krishnan J; Nelson A; Polage CR; Sinkowitz-Cochran RL; Fike L; Kuhar DT; Kutty PK; Snyder RL; Anderson DJ
    JAMA Netw Open; 2024 Mar; 7(3):e243846. PubMed ID: 38536174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of adding prophylactic probiotics to a bundle of standard preventative measures for Clostridium difficile infections: enhanced and sustained decrease in the incidence and severity of infection at a community hospital.
    Maziade PJ; Andriessen JA; Pereira P; Currie B; Goldstein EJ
    Curr Med Res Opin; 2013 Oct; 29(10):1341-7. PubMed ID: 23931498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
    Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
    Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.